BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38837261)

  • 1. Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy.
    Colen J; Nguyen C; Liyanage SW; Aliotta E; Chen J; Alonso C; Romano K; Peach S; Showalter T; Read P; Larner J; Wijesooriya K
    Med Phys; 2024 Jun; ():. PubMed ID: 38837261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Chen G; Zeng Z; He J
    Front Oncol; 2019; 9():1488. PubMed ID: 32039000
    [No Abstract]   [Full Text] [Related]  

  • 4. Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis.
    Pham J; Neilsen BK; Liu H; Cao M; Yang Y; Sheng K; Ma TM; Kishan AU; Ruan D
    Med Phys; 2024 Jan; 51(1):612-621. PubMed ID: 38055353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Learning-based dose prediction for pancreatic stereotactic body radiation therapy using dual pyramid adversarial network.
    Momin S; Lei Y; Wang T; Zhang J; Roper J; Bradley JD; Curran WJ; Patel P; Liu T; Yang X
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34087807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of the Kinetics of Radiation-Induced Lymphocyte Loss in Patients Treated with External Beam Radiation Therapy.
    Ellsworth SG; Yalamanchali A; Zhang H; Grossman SA; Hobbs R; Jin JY
    Radiat Res; 2020 Jan; 193(1):73-81. PubMed ID: 31675264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the use of a convolution-superposition algorithm for plan checking in lung stereotactic body radiation therapy.
    Hardcastle N; Oborn BM; Haworth A
    J Appl Clin Med Phys; 2016 Sep; 17(5):99-110. PubMed ID: 27685114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy.
    Reddy AV; Deek MP; Jackson JF; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    Radiat Oncol; 2021 Dec; 16(1):242. PubMed ID: 34952610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy.
    Reddy AV; Hill CS; Sehgal S; Zheng L; He J; Laheru DA; Jesus-Acosta A; Herman JM; Meyer J; Narang AK
    Radiat Oncol J; 2022 Jun; 40(2):111-119. PubMed ID: 35796114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
    Front Oncol; 2021; 11():728519. PubMed ID: 34912703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A treatment planning comparison between modulated tri-cobalt-60 teletherapy and linear accelerator-based stereotactic body radiotherapy for central early-stage non-small cell lung cancer.
    Merna C; Rwigema JC; Cao M; Wang PC; Kishan AU; Michailian A; Lamb J; Sheng K; Agazaryan N; Low DA; Kupelian P; Steinberg ML; Lee P
    Med Dosim; 2016; 41(1):87-91. PubMed ID: 26755076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Zhao Q; Li T; Du S; He J; Zeng Z
    Technol Cancer Res Treat; 2022; 21():15330338221112287. PubMed ID: 35816375
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of photon optimizer (PO) MLC algorithm for stereotactic, single-dose of VMAT lung SBRT.
    Visak J; McGarry RC; Pokhrel D
    Med Dosim; 2020 Winter; 45(4):321-326. PubMed ID: 32444208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiblock Discriminant Analysis of Integrative
    Lee SH; Kao GD; Feigenberg SJ; Dorsey JF; Frick MA; Jean-Baptiste S; Uche CZ; Cengel KA; Levin WP; Berman AT; Aggarwal C; Fan Y; Xiao Y
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1451-1465. PubMed ID: 33662459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program.
    Dunlap N; McIntosh A; Sheng K; Yang W; Turner B; Shoushtari A; Sheehan J; Jones DR; Lu W; Ruchala K; Olivera G; Parnell D; Larner JL; Benedict SH; Read PW
    Med Dosim; 2010; 35(4):312-9. PubMed ID: 21055611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Halcyon feasible for single thoracic or lumbar vertebral segment SBRT?
    Li F; Park J; Lalonde R; Jang SY; diMayorca MS; Flickinger JC; Keller A; Huq MS
    J Appl Clin Med Phys; 2022 Jan; 23(1):e13458. PubMed ID: 34845817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition.
    Kraus KM; Oreshko M; Bernhardt D; Combs SE; Peeken JC
    Front Oncol; 2023; 13():1124592. PubMed ID: 37007119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated robust SBPT planning using EUD-based prediction of SBRT plan for patients with lung cancer.
    Wei L; Wang W; Dai Z; Li Y; Shang H
    Comput Methods Programs Biomed; 2021 Sep; 209():106338. PubMed ID: 34390935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-aware 3D U-Net convolutional neural network for knowledge-based planning 3D dose distribution prediction of head-and-neck cancer.
    Osman AFI; Tamam NM
    J Appl Clin Med Phys; 2022 Jul; 23(7):e13630. PubMed ID: 35533234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and clinical validation of a robust knowledge-based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors.
    Visak J; McGarry RC; Randall ME; Pokhrel D
    J Appl Clin Med Phys; 2021 Jan; 22(1):146-155. PubMed ID: 33285034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.